Detalles de la búsqueda
1.
World Health Organization package of interventions for rehabilitation for cancer: a MASCC-endorsed resource for global action to address unmet rehabilitation needs of people affected by cancer.
Support Care Cancer;
32(7): 417, 2024 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38847912
2.
Real-world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer.
Cancer Med;
13(12): e7317, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38895891
3.
The survival benefit of adjuvant trastuzumab with or without chemotherapy in the management of small (T1mic, T1a, T1b, T1c), node negative HER2+ breast cancer.
NPJ Breast Cancer;
10(1): 49, 2024 Jun 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38898072
4.
Characterization of time toxicity in older patients with metastatic breast cancer.
Breast Cancer Res Treat;
2024 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38816556
5.
An Open-Label Study of Subcutaneous CpG Oligodeoxynucleotide (PF03512676) in Combination with Trastuzumab in Patients with Metastatic HER2+ Breast Cancer.
Cancer Control;
31: 10732748241250189, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38797949
6.
Eyebrow and Eyelash Loss in Patients With Cancer.
J Drugs Dermatol;
23(5): 327-331, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38709698
7.
Survivorship Care for People Affected by Advanced or Metastatic Cancer: MASCC-ASCO Standards and Practice Recommendations.
JCO Oncol Pract;
: OP2300716, 2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38684036
8.
A retrospective cohort study describing chemotherapy-induced peripheral neuropathy in Non-Hodgkin lymphoma patients treated with EPOCH ± R: does HIV status matter?
Leuk Lymphoma;
: 1-7, 2024 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38648546
9.
The effect of using a large language model to respond to patient messages.
Lancet Digit Health;
6(6): e379-e381, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38664108
10.
Survivorship care for people affected by advanced or metastatic cancer: MASCC-ASCO standards and practice recommendations.
Support Care Cancer;
32(5): 313, 2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38679639
11.
The Right Dose: Results of a Patient Advocate-Led Survey of Individuals With Metastatic Breast Cancer Regarding Treatment-Related Side Effects and Views About Dosage Assessment to Optimize Quality of Life.
JCO Oncol Pract;
: OP2300539, 2024 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38518184
12.
Promise and Perils of Large Language Models for Cancer Survivorship and Supportive Care.
J Clin Oncol;
42(14): 1607-1611, 2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38452323
13.
Feasibility and metabolic outcomes of a well-formulated ketogenic diet as an adjuvant therapeutic intervention for women with stage IV metastatic breast cancer: The Keto-CARE trial.
PLoS One;
19(1): e0296523, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38166036
14.
Randomized placebo-controlled, double-blind clinical trial of nanoemulsion curcumin in women with aromatase inhibitor-induced arthropathy: an Alliance/NCORP pilot trial.
Breast Cancer Res Treat;
205(1): 61-73, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38280052
15.
Online description of services provided in adult survivorship programs across U.S. accredited cancer centers.
J Cancer Surviv;
18(1): 79-83, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36933086
16.
Prevalence of targetable genomic alterations in young women with advanced breast cancer: a cross-sectional study.
Breast Cancer Res Treat;
204(1): 181-185, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37999916
17.
Post-diagnosis weight trajectories and mortality among women with breast cancer.
NPJ Breast Cancer;
9(1): 98, 2023 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38042922
18.
Patient perceptions of altering chemotherapy treatment due to peripheral neuropathy.
Support Care Cancer;
32(1): 48, 2023 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38129602
19.
Phase Ib study of HSP90 inhibitor, onalespib (AT13387), in combination with paclitaxel in patients with advanced triple-negative breast cancer.
Ther Adv Med Oncol;
15: 17588359231217976, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38152697
20.
Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients.
Support Care Cancer;
31(12): 717, 2023 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37991653